🚀 VC round data is live in beta, check it out!
Simris Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Simris Group and similar public comparables like 7FIT, Enorama Pharma, NUTEX, Arctic Bioscience and more.
Simris Group Overview
About Simris Group
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
Founded
2010
HQ
Employees
7
Website
Financials (FY)
EV
$7M
Simris Group Financials
Simris Group reported last fiscal year revenue of $175K and negative EBITDA of ($2M).
In the same fiscal year, Simris Group generated $191K in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).
Simris Group P&L
In the most recent fiscal year, Simris Group reported revenue of $175K and EBITDA of ($2M).
Simris Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $175K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $191K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 109% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (962%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (1831%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (1660%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Simris Group Stock Performance
Simris Group has current market cap of $7M, and enterprise value of $7M.
Market Cap Evolution
Simris Group's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $7M | (0.9%) | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSimris Group Valuation Multiples
Simris Group trades at 41.1x EV/Revenue multiple, and (4.3x) EV/EBITDA.
Simris Group Financial Valuation Multiples
As of March 13, 2026, Simris Group has market cap of $7M and EV of $7M.
Equity research analysts estimate Simris Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Simris Group has a P/E ratio of (2.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 41.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 37.6x | XXX | XXX | XXX |
| P/E | — | XXX | (2.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Simris Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Simris Group Margins & Growth Rates
Simris Group's revenue in the last fiscal year declined by (44%).
Simris Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (44%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (962%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (12%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1940% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Simris Group Public Comps
See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| 7FIT | XXX | XXX | XXX | XXX | XXX | XXX |
| Enorama Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| NUTEX | XXX | XXX | XXX | XXX | XXX | XXX |
| Arctic Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Stem Cells Spin | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Simris Group M&A Activity
Simris Group acquired XXX companies to date.
Last acquisition by Simris Group was on XXXXXXXX, XXXXX. Simris Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Simris Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSimris Group Investment Activity
Simris Group invested in XXX companies to date.
Simris Group made its latest investment on XXXXXXXX, XXXXX. Simris Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Simris Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Simris Group
| When was Simris Group founded? | Simris Group was founded in 2010. |
| Where is Simris Group headquartered? | Simris Group is headquartered in Sweden. |
| How many employees does Simris Group have? | As of today, Simris Group has over 7 employees. |
| Is Simris Group publicly listed? | Yes, Simris Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Simris Group? | Simris Group trades under SIMRIS B ticker. |
| When did Simris Group go public? | Simris Group went public in 2016. |
| Who are competitors of Simris Group? | Simris Group main competitors are 7FIT, Enorama Pharma, NUTEX, Arctic Bioscience. |
| What is the current market cap of Simris Group? | Simris Group's current market cap is $7M. |
| What is the current revenue of Simris Group? | Simris Group's last fiscal year revenue is $175K. |
| What is the current EV/Revenue multiple of Simris Group? | Current revenue multiple of Simris Group is 41.1x. |
| Is Simris Group profitable? | No, Simris Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.